Product image of Natriumthiosulfaat Hope (Sodium Thiosulfate) supplied by GNH India

Natriumthiosulfaat Hope

Active Ingredient:
Sodium Thiosulfate
Origin:
EU

Natriumthiosulfaat Hope (Sodium Thiosulfate)

Sodium Thiosulfate, the active ingredient in Natriumthiosulfaat Hope, is a chelating agent presented as an injectable solution for intravenous use. It is employed as an antidote for cyanide poisoning and as a treatment option in calciphylaxis and radiation‑induced mucositis.

GNH India supplies Natriumthiosulfaat Hope as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Hope Pharmaceuticals Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Sodium Thiosulfate is used in clinical situations that require detoxification of cyanide or calcium chelation.

  • Cyanide poisoning: rapidly converts cyanide to the less toxic thiocyanate for renal excretion.
  • Calciphylaxis: chelates calcium deposits in small vessels, helping to reduce painful skin lesions.
  • Radiation‑induced mucositis: mitigates mucosal injury and promotes healing in patients receiving radiotherapy.

How It Works

  • Sodium Thiosulfate acts as a sulfur donor for the mitochondrial enzyme rhodanese, facilitating the conversion of cyanide to thiocyanate, which is then eliminated by the kidneys. In calciphylaxis, it binds calcium ions, forming soluble complexes that reduce vascular calcification and improve tissue perfusion.

Side Effects

Sodium Thiosulfate may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Hypotension: transient drop in blood pressure during infusion.
  • Headache: occasional mild headache during or after administration.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction requiring immediate medical attention.
  • Metabolic acidosis: significant acid‑base disturbance, especially in renal impairment.
  • Renal impairment: worsening kidney function in susceptible patients.
  • Hemolysis: breakdown of red blood cells, observed rarely.
  • Arrhythmia: irregular heart rhythm in high‑risk individuals.

Precautions & Warnings

When using Sodium Thiosulfate, clinicians should consider several safety measures.

  • Renal function: evaluate baseline kidney function and monitor during therapy.
  • Blood pressure: observe for hypotension, especially during rapid infusion.
  • Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
  • Concomitant cyanide sources: avoid exposure to additional cyanide‑generating agents.
  • Calcium supplements: assess need, as they may diminish chelation efficacy.
  • Store at ambient temperature: keep in the original container, protect from light and moisture.

Avoid Interactions

Sodium Thiosulfate can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Nitroprusside: may increase cyanide production, worsening toxicity.
  • High‑dose vitamin B12: can interfere with thiosulfate metabolism.
  • Calcium supplements: may reduce the drug's calcium‑chelation effect.

Moderate Interactions (Monitor Closely)

  • Loop diuretics: may alter electrolyte balance, necessitating monitoring.
  • ACE inhibitors: can potentiate hypotensive effects during infusion.
  • Anticoagulants: may increase bleeding risk, requiring careful observation.

Frequently Asked Questions

Natriumthiosulfaat Hope contains sodium thiosulfate and is used as an antidote for cyanide poisoning, as a calcium‑chelating agent in calciphylaxis, and to alleviate radiation‑induced mucositis. These indications rely on its ability to detoxify cyanide and bind calcium, helping to protect tissues and improve clinical outcomes.

Sodium thiosulfate donates sulfur to the enzyme rhodanese, which converts toxic cyanide into thiocyanate, a compound that is readily eliminated by the kidneys. In calciphylaxis, it forms soluble complexes with calcium, reducing vascular calcification and supporting tissue healing.

The specific dose of Natriumthiosulfaat Hope is determined by the prescribing clinician based on the patient’s condition, severity, weight, and renal function. Healthcare professionals calculate the appropriate amount and infusion rate according to established clinical guidelines.

Safety data for sodium thiosulfate in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Natriumthiosulfaat Hope, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Sodium thiosulfate is often used together with hydroxocobalamin; unlike hydroxocobalamin, which directly binds cyanide, thiosulfate acts as a sulfur donor for enzymatic conversion to thiocyanate. It is also less likely to cause discoloration of bodily fluids, but may require careful monitoring of renal function.

Natriumthiosulfaat Hope should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from direct sunlight, moisture and extreme temperature fluctuations to maintain stability and potency.

The product is supplied as an injectable solution for intravenous infusion. Administration is performed by qualified healthcare personnel, typically via a controlled infusion pump, with infusion rates adjusted according to the clinical protocol and patient tolerance.

Serious risks include anaphylactic reactions, severe hypotension, metabolic acidosis, renal impairment, hemolysis and cardiac arrhythmias. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after infusion.

Patients with known hypersensitivity to sodium thiosulfate or any component of the formulation should avoid its use. Caution is also advised for individuals with severe renal impairment, uncontrolled hypotension, or those receiving concurrent nitroprusside therapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.